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Abstract
Background: Plasmodium falciparum is the protozoan parasite primarily responsible for more than one million
malarial deaths, annually, and is developing resistance to current therapies. Throughout its lifespan, the parasite is
subjected to oxidative attack, so Plasmodium antioxidant defences are essential for its survival and are targets for
disease control.
Results: To further understand the molecular aspects of the Plasmodium redox system, we solved 4 structures of
Plasmodium peroxiredoxins (Prx). Our study has confirmed PvTrx-Px1 to be a hydrogen peroxide (H2O2)-sensitive
peroxiredoxin. We have identified and characterized the novel toroid octameric oligomer of PyTrx-Px1, which may
be attributed to the interplay of several factors including: (1) the orientation of the conserved surface/buried
arginine of the NNLA(I/L)GRS-loop; and (2) the C-terminal tail positioning (also associated with the aforementioned
conserved loop) which facilitates the intermolecular hydrogen bond between dimers (in an A-C fashion). In
addition, a notable feature of the disulfide bonds in some of the Prx crystal structures is discussed. Finally, insight
into the latter stages of the peroxiredoxin reaction coordinate is gained. Our structure of PyPrx6 is not only in the
sulfinic acid (RSO2H) form, but it is also with glycerol bound in a way (not previously observed) indicative of
product binding.
Conclusions: The structural characterization of Plasmodium peroxiredoxins provided herein provides insight into
their oligomerization and product binding which may facilitate the targeting of these antioxidant defences.
Although the structural basis for the octameric oligomerization is further understood, the results yield more
questions about the biological implications of the peroxiredoxin oligomerization, as multiple toroid configurations
are now known. The crystal structure depicting the product bound active site gives insight into the overoxidation
of the active site and allows further characterization of the leaving group chemistry.
Background
There are at least 500 million clinical episodes of
malaria annually with more than a million Africans
dying each year, most of whom are children under 5
years of age [1]. The causative agent for the most lethal
form of malaria is a protozoan parasite, Plasmodium fal-
ciparum, while P. vivax causes a less severe form, P.
knowlesi is responsible for macaque malaria (but it can
also infect humans [2,3]), and P. yoelii and berghei infect
rodents. Plasmodium parasites are frequently subject to
oxidative attack, for example, in the erythrocyte from
H2O2 release during heme metabolism and from NO
and reactive oxygen species (ROS) generation during the
host immune response [4,5]. In addition, oxidative stress
is sustained during the sexual maturation of the parasite
within the Anopheles mosquito midgut and salivary
gland prior to transmission [6,7]. As such, Plasmodium
antioxidant defences are essential to its survival, and
thus are expected to be targets for the effective control
of the disease [8,9].
Interestingly, neither the Plasmodium parasites nor
the trypanosomes contain a catalase or a selenocysteine-
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enzymes notably efficient for the detoxification of
hydroperoxides [10,11]. Plasmodium does however pos-
sess 2 superoxide dismutases, 6 proteins homologous to
thiol-dependent peroxidases, and a glutathione-S-trans-
ferase (GST). The GST has only weak GSH peroxidase
activity, but it might contribute significantly to the anti-
oxidant capacity of the parasite due to its high concen-
tration [12]. Of those homologous to the thiol-
dependent peroxidases, there is the GPx-like thioredoxin
peroxidase, which is a non-selenocysteine GPx known to
be significantly less active than its selenium homologue
[13]. The 5 remaining thiol-dependent peroxidase
homologues identified in Plasmodium include thiore-
doxin peroxiredoxin 1 and 2 (Trx-Px1 and Trx-Px2)
from the peroxiredoxin subfamily Prx1, a 1-Cys peroxir-
edoxin (1-Cys Prx) from the Prx6 subfamily, antioxidant
protein (AOP) from subfamily Prx5, and a very recently
characterized nuclear peroxiredoxin (PfnPRx) [14]
(Table 1). Interestingly, peroxiredoxins have recently
been implicated in a different role, namely as a non-
transcriptional rhythmic marker, indicative of the
circadian clock [19]. Various strategies have been used
to classify the members of the peroxiredoxin family
including a phylogenetic tree analysis that categorizes
them into 6 subfamilies (Prx1, Prx6, Prx5, Trx-Px, BCP,
and AhpE), each of which may include the mechanisti-
cally distinct 1-Cys and 2-Cys peroxiredoxins [20,21].
All peroxiredoxins contain a conserved cysteine resi-
due at the N-terminus that is referred to as the peroxi-
datic cysteine (CP). During catalysis, it is oxidized by the
ROS substrate (generally H2O2 or an alkyl hydroperox-
ide) to sulfenic acid (Cys-S-OH). Typical 2-Cys Prx con-
tain 2 conserved cysteines, including the CP and a C-
terminal cysteine (termed the resolving Cys (CR)). Dur-
ing catalysis, the CP sulfenic acid reacts with the CR of
the adjacent monomer to form the intermolecular disul-
fide of the homodimer that is subsequently reduced by
another (undetermined) thiol. In 1-Cys Prx, the CP sul-
fenic acid is directly reduced by an unidentified redox
partner.
Building on the dimer formation, the 2-Cys Prx
enzymes organize themselves into higher order oligo-
mers, such as decamers, which have higher peroxidase
Table 1 Plasomodium peroxiredoxin orthologues and corresponding PDB codes for solved structures
Subfamily Name Mechanistic
Classification
Cellular
Location
PlasmoDB ID PDB ID Reference
Prx1 PfTrx-Px1 2-Cys (C50, C170) cytosolic PF14_0368 [15]
PvTrx-Px1 2-Cys (C50, C170) cytosolic PVX_118545 (2H66, 2I81) this work
PyTrx-Px1 2-Cys (C50, C170) cytosolic PY00414 (2H01) this work
PbTrx-Px1 2-Cys (C50, C169) cytosolic PB000037.01.0
PkTrx-Px1 2-Cys (C50, C170) cytosolic PKH_126740
PfTrx-Px2 2-Cys (C67, C187) mitochondrial PFL0725w (2C0D) [15,16]
PvTrx-Px2 2-Cys (C67, C187) mitochondrial PVX_123435
PyTrx-Px2 2-Cys (C67, C187) mitochondrial PY02747
PbTrx-Px2 2-Cys (C59, C179) mitochondrial PB001545.02.0
PkTrx-Px2 2-Cys (C67, C187) mitochondrial PKH_143220
Prx6 PfTrx-Px1 1-Cys (C47) cytosolic PF08_0131
PvTrx-Px1 1-Cys (C47) cytosolic PVX_093630
PyTrx-Px1 1-Cys (C47) cytosolic PY04285 (3TB2) this work
PbTrx-Px1 1-Cys (C47) cytosolic PB000600.02.0
PkTrx-Px1 1-Cys (C47) cytosolic PKH_011610
Prx5 PfTrx-Px1 1-Cys (C117) apicoplast MAL7P1.159 (1XIY) [17]
PvTrx-Px1 1-Cys (C114) apicoplast PVX_081760
PyTrx-Px1 1-Cys (C122) apicoplast PY01475
PbTrx-Px1 1-Cys (C28) apicoplast PB000177.01.0
PkTrx-Px1 1-Cys (C114) apicoplast PKH_021360
BCP PfnPrx 1-Cys (C56) nuclear PF10_0268 [14,18]
PvnPrx 1-Cys (C52) nuclear PVX_111355
PynPrx 1-Cys (C52) nuclear PY03834
PbnPrx 1-Cys (C61) nuclear PBANKA_051140
PknPrx 1-Cys (C52) nuclear PKH_061160
Abbreviations include: Pf, P. falciparum; Pv, P. vivax; Py, P. yoelii; Pb, P. berghei; and Pk, P. knowlesi. Cellular location from experimental result, from result of
orthologue, or from predictive targeting sequences. Mechanistic classification from experiment or based on experimental result and sequence alignment of
orthologue
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dependent on the redox state of CP (and CR), as well as
other factors [22,23]. Both Trx-Px1 and Trx-Px2 have
been identified as typical 2-Cys Prx enzymes; and a crys-
tal structure of P. falciparum Trx-Px2 (PDB ID: 2C0D)
has been published [16]. Distinguishing these two Plas-
modium thioredoxin peroxidases is their cellular loca-
tion, as Trx-Px1 is predicted to be cytosolic and Trx-
Px2 has a mitochondrial targeting sequence [15]. Both
features were recently confirmed [24]. Like the Plasmo-
dium 1-Cys Prx from subfamily Prx6, AOP is also a 1-
Cys Prx; and the P. falciparum AOP structure has been
s o l v e d( P D BI D :1 X I Y )[ 1 7 ] .A O Pi st h o u g h tt ob ea n
apicoplast enzyme due to its N-terminal signal motif,
while the other Plasmodium 1-Cys Prx is cytosolic. Both
predictions were recently confirmed experimentally [24].
Prx enzymes are highly expressed in Plasmodium (0.5%
of cellular protein) and have been predicted from com-
petitive kinetic analysis with human cells to be responsi-
ble for the reduction of 90% of mitochondrial H2O2 and
nearly 100% of cytoplasmic H2O2 [25].
In order to further the understanding of the molecular
details of the Plasmodium redox system, we solved the
crystal structures of Trx-Px1 from P. vivax (PvTrx-Px1)
in the reduced and oxidized forms, Trx-Px1 from P. yoe-
lii (PyTrx-Px1) in the oxidized form, and a 1-Cys Prx
from P. yoelii (termed PyPrx6, herein) with CP oxidized
to the sulfinic acid and with glycerol bound within the
active site pocket. In addition, we have structurally con-
firmed and characterized the PvTrx-Px1 as a H2O2-sen-
sitive peroxiredoxin; PyTrx-Px1 as forming an octamer
(instead of the typical decamer and dodecamer arrange-
ments); and PyPrx6 as a product bound complex reveal-
ing some interesting features of these enzymes.
Results
Expression and initial characterization of Trx-Px1 from P.
falciparum, P. vivax, P. yoelii, and P. knowlesi and Prx6
from P. yoelii
Constructs of the Trx-Px1 enzymes from P. falciparum,
P. vivax, P. yoelii,a n dP. knowlesi were expressed and
purified as described previously [26]. PyPrx6 was also
expressed in Studier auto-induction media [27]. All were
full length constructs except PyTrx-Px1 which was also
expressed for crystallization with a 6-residue truncation
at the N-terminus. According to our mass spectroscopic
analysis, all of our purified Trx-Px1 enzymes were disul-
fide-linked dimers (Table 2). As verified by mass spec-
troscopy, each of the 4 purified Trx-Px1 enzymes could
be completely reduced using 20 mM dithiothreitol
(Table 2).
By analytical gel filtration, all of the purified Trx-Px1
constructs (oxidized form and at high μM concentra-
tions) eluted primarily as the higher order oligomer (i.e.
octamer or decamer or dodecamer) (data not shown).
Oligomerization has been shown to be dependent on
numerous factors including ionic strength, pH, concen-
tration of divalent metals, and most importantly redox
state [28]. In our gel filtration, a small amount of pre-
sumably aggregated protein was followed by the oligo-
meric protein around (corresponding to a calculated
mass of 272 or 314 kDa). In the case of PfTrx-Px1,
some presumably dimeric protein was also observed,
which was not noticed in previous gel filtration analyses
of PfTrx-Px1 by Akerman and coworkers. [29]. These
authors only observed higher order oligomers corre-
sponding to 400 and 250 kDa for PfTrx-Px-1 and
further detected the (a2)5 quaternary form by electron
microscopy.
Table 2 Mass spectroscopy of reduced and oxidized Plasmodium Trx-Px-1 orthologues
Expected MW of
Reduced Monomer
Expected MW of
Oxidized Dimer
Purified Enzyme
(Da)
Purifed Enzyme +
20 mM DTT (Da)
PfTrx-Px1 23702.08 47400.12 47456.56 (99%+)
23729.32 (trace)
a
23730.96
PvTrx-Px1 23567.94 47131.84 47133.20 (major)
23568.94 (minor)
23568.77
PyTrx-Px1 23534.86 47065.68 47066.49 (99%+)
23533.70 (trace)
23533.70
PyTrx-Px1:
Q7-L195
23234.40 46468.76 46470.60(99%+)
23234.49 (trace)
23235.18
PkTrx-Px1 24225.58 48447.12 48449.43 (99%+)
24226.10 (trace)
24226.38
The calculated MW in Da is determined from the amino acid sequence and includes the His6-tag incorporated into our constructs. The expected monomer MW is
determined from the calculated monomer MW and subtracts the known E. coli post translational modification, namely clipping of the N-terminal Met (-131.19) of
the His6-tag [26]. The expected MW of the oxidized dimer is calculated by doubling the expected MW weight of the monomer (clipping of the N-terminal Met
accounted for) and subtracting 4 H (-4.04).
aThe MW of the purified monomeric PfTrx-Px-1 is off by 28 Da (and the dimer is off by twice this) which may be
accounted for by one of the following: addition of ethyl addition, N, N-dimethylation of Arg or Lys, 2,4 bis-Trp-6,7-dione formation, or addition of formaldehyde
(CHO)
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from our typical protocol was purified in the reduced
form according to mass spectroscopy (27189.1 Da) with-
out addition of exogenous reducing agents (with the
expected molecular weight after cleavage of the N-term-
inal Met weight being 27188.2 Da), while PyPrx6
expressed from Studier auto-induction media was puri-
fied in the sulfinic acid form (see below). From a cali-
brated gel filtration column, the enzyme eluted at 220
mL (corresponding to a calculated gel filtration mass of
62 kDa) which is consistent with the expected behaviour
of a dimer.
Crystal structures of Trx-Px1 from P. vivax and P. yoelii
The crystal structures of P. vivax Trx-Px1 were solved
in both the reduced (PvTrx-Px1_red, PDB ID: 2I81) and
oxidized forms (PvT r x - P x 1 _ o x ,P D BI D :2 H 6 6 )a t2 . 4 5
Å and 2.5 Å, respectively (Figure 1). Aside from these 2
structures, to date only rat and Salmonella typhimurium
Prx1 subfamily structures have been solved in both fully
reduced and oxidized (as the disulfide) redox states [21].
In comparison to other solved structures, PvTrx-Px1 is
most similar (52% sequence identity) to PfTrx-Px2 [16].
It has 85% sequence identity with PfTrx-Px1 and 47%
identity to its closest human orthologues. Herein, the
oxidized form of PyTrx-Px1 has also been solved to 2.3
Å (PDB ID: 2H01) (Figure 1C).
The structures of each (PvTrx-Px1_red, PvTrx-Px1_ox,
and PyTrx-Px1_ox) contain the typical thioredoxin-fold
found in known peroxiredoxins. There is a central 7-
stranded b-sheet comprised of b2-b1-b5-b4-b3-b6-b7
with b1a n db6 running anti-parallel relative to the other
strands. This b-sheet is sandwiched by a1 and a4o no n e
side and a2, a3, and a5 on the other side. The root
mean square deviation (rmsd) between PvTrx-Px1_ox,
and PyTrx-Px1_ox is 0.91 Å when superimposing over
the monomer encompassing Ca’s from residues 2 to 177.
The remaining residues of the C-terminus are disordered
(from 178 to 195) in the PvTrx-Px1_ox structure.
In PvTrx-Px1_red structure, the CP residue (Cys50 for
P. vivax) is located at the first turn of helix a2a tt h e
end of a narrow accessible channel formed by a loop-
helix motif and surrounded by 3 conserved residues
Pro43, Thr47, and Arg125 (Figure 2A, red/dark grey).
The pyrrolidine ring of Pro43 limits solvent accessibility
and protects the reactive cysteinyl sulfenic acid from
further oxidation during catalysis. The distance between
Cys50 and the corresponding CR thiol from its dimeric
partner is 13.5 Å in the reduced form. In both the oxi-
dized structures of PvTrx-Px1_ox and PyTrx-Px1_ox,
the a2 helix is locally unfolded (LU) around the CP,
such that the a2 helix begins after the CP with Ser52
(coloured in orange in Figure 2A for Pv and Py: PvTrx-
Px1_ox) or Ser46 (Figure 2B for PyTrx-Px1_ox). Some
conserved residues that form the active site in the
reduced structure are in the same positions and orienta-
tions in both the oxidized structures (Pro43, Thr47, and
Arg125 for PvTrx-Px1, Figure 2A, orange/light grey and
Pro37, Thr41, and Arg119 for PyTrx-Px1, Figure 2B).
The CP has rotated to the surface as part of a highly
exposed loop; and SP (sulfur of CP) is engaged in a dis-
ulfide bond with SR (sulfur of CR)o ft h ee n z y m e ’s
dimeric partner forming a domain swapped homodimer.
PvTrx-Px1 and PyTrx-Px1 are H2O2-sensitive
peroxiredoxins
The 3 sequence motifs that define the H2O2-sensitive
peroxiredoxins include: (1) the conserved loop-helix
from Pro43 to Glu53 surrounding the CP;( 2 )a3 10
helix-loop from Pro89 to Ile98; and (3) the 29 C-term-
inal residues from Gly167 including CR and conserved
bulky residues [30]. The loop-helix is completely con-
served among human, rat, and Plasmodium peroxire-
doxins. However, the Plasmodium enzymes are a slight
variation of 310 helix-loop and C- t e r m i n a lt a i lm o t i f s
with sequences including
93GGIG
96 and
191YL
192,
respectively, instead of the typical GGLG and YF (Figure
3A). Upon addition of 500 μMt o5m MH 2O2 to
reduced (by DTT) PfTrx-Px1, PvTrx-Px1, PkTrx-Px1, or
PyTrx-Px1 enzymes, additions of 2 and 3 oxygen atoms
were observed by mass spectroscopy, confirming that
these enzymes are H2O2-sensitive. Structurally, the first
loop-helix and the C-terminal arm of P. falciparum
were predicted by modelling to undergo the same struc-
tural rearrangement during catalysis as the mammalian
peroxiredoxins [31]. Figure 3B, 3C illustrate the struc-
tural changes that PvTrx-Px1 does indeed undergo dur-
ing catalysis further supporting its characterization as a
H2O2-sensitive peroxiredoxin. Although predicted by
K a w a z u[ 3 1 ] ,t ob ef l u i d( i.e. structurally disordered)
from Pro171 immediately following CP,t h eC-terminal
tail is an ordered loop from Pro171 to Gly177 in the
PvTrx-Px1_ox structure. The PyTrx-Px1_ox structure
also shows a similar arrangement of conserved residues,
a3 10 helix-loop motif at
90PLSQGGIGNI
98,a n daC-
terminal tail bearing a
191YL
192 motif (nearly identical to
PvTrx-Px1 that folds upon reduction into a loop fol-
lowed by an a-helix), so it is also expected to be a
H2O2-sensitive peroxiredoxin (Figure 2B and 3A). The
conserved
191YL
192 motif that is located on the a-helix
close to the surface stabilizes the full-folded conforma-
tion. This motif therefore slows the resolution reaction
and allows overoxidation by reaction with a second
equivalent of peroxide. In contrast robust peroxiredox-
ins do not have residues protecting the CP and are
quickly oxidized to the disulfide [30].
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Page 4 of 18Figure 1 Structures of the dimeric units of the Plasmodium peroxiredoxins. The structures of the dimeric units of the peroxiredoxins with
the CP and CR thiol side chains are shown to display the secondary structure in one of the monomers with a-helices shown in blue, b-sheets
shown in pink, and sulfur and oxygen atoms displayed in yellow and red, respectively. (A) PvTrx-Px1_ox is shown with only one disulfide visible,
as the second one is not visible due to the lack of structure at the C-terminus (thus CR) of the monomer shown with secondary structure
colours. (B) PvTrx-Px1_red with all 4 reduced thiols clearly visible. (C) PyTrx-Px1_ox with the 2 disulfides clearly displayed; and (D) PyPrx6 is
shown with its sulfinic acid active site cysteine and with glycerol bound.
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structures
Upon examination of each dimer of PvTrx-Px1_ox deca-
mer ((a2)5 oligomer) (Figures 1A and 4A), only 4 of a
possible 10 disulfide bonds are clearly defined in the
crystal structure. There is inadequate density to define
the C-terminal tail from around the CR for the remain-
ing residues, so that for several of the monomers only
the side chain of CP but not that of CR is visible. In the
case of the PyTrx-Px1_ox octamer ((a2)4 oligomer) (Fig-
ures 1C and 4B) (for which the data was collected at a
home source) the Cys-SP to Cys-SR distances measure
~3 Å (notably, bond lengths at the resolution of these
structures are derived from a combination of x-ray data
and chemical constraints). There are no reports indicat-
ing that disulfide bonds are labile under the conditions
used in our PyTrx-Px1 experiments. As expected, the C-
terminal tails of PvTrx-Px1 and PyTrx-Px1 have higher
B-factors than the other parts of the molecule, indicative
of a more fluid region and also of the apparent absence
of detectable disulfide bonds in portions of the PvTrx-
Px1 structure and the distortion of the disulfide bond
length in the PyTrx-Px1 structure. In previously pub-
lished crystal structures of oxidized 2-Cys Prx, the Cys-
SP to Cys-SR distance is also longer than expected for a
disulfide bond (as the typical bond length is 2.05 for a
disulfide). For example in the structure of a 2-Cys Prx
from Helicobacter pylori (HpAhpC) (PDB ID: 1ZOF),
the Cys-SP to Cys-SR distances measurements range
from 2.0 to 3.2 Å and in a P. falciparum 2-Cys Prx
(PfTrx-Px2) (PDB ID: 2C0D) one of the disulfides is
shown in two different orientations (2.0-2.2 Å) indicative
of the structural flexibility of these structures, while the
other measures at 2.6 Å. Our analysis using mass spec-
troscopy (already discussed) and the overall structural
configurations (i.e. local unfolding about CP a n da tt h e
C-terminus) both support PvTrx-Px1_ox and PyTrx-
Px1_ox being in the oxidized form making these long
Cys-SP to Cys-SR distances not easily accounted for, yet
prevalent in the Prx1 subfamily.
Oligomeric organization of PvTrx-Px1 and PyTrx-Px1
Oligomeric peroxiredoxins are formed via at least 2
types of interactions: (1) B-type interactions where edge
to edge associations of b7 strands of the central sheet
meet to extend it into a 14-stranded b-sheet; and (2) A-
type where the interface is a tip to tip association
centred on helices a4 and a5 packing against helices a4
Figure 2 PvTrx-Px1 and PyTrx-Px1 active sites. (A) Active sites of PvTrx-Px1_red and PvTrx-Px1_ox are shown in red/dark grey and orange/
light grey, respectively. Note the positioning of Pro43, Thr47, and Arg125 are unchanged between the reduced and oxidized forms. The
dramatic change of the active site CP in the reduced form (red) is shown as untwisting of the helix to meet the CR from its dimeric partner. As
well, the formation of the disulfide results in the disruption of the final C-terminal a-helix. Note that in the reduced form the CP and CR are
separated by 13.5 Å. (B) Active site of PyTrx-Px1_ox is shown for comparison.
Qiu et al. BMC Structural Biology 2012, 12:2
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Page 6 of 18and a5 of the other chain [17]. The dimer interface of
the PvTrx-Px1_ox and PyTrx-Px1_ox (i.e.w h e r et h e
interactions resulting at the surfaces formed by the dis-
ulfide bond) is termed the B-type interaction face.
Accordingly, the same dimeric unit is expected in the
reduced structures. These dimers then associate via A-
type interactions to form the higher order oligomers,
which are typically decameric and dodecameric. PvTrx-
Figure 3 PvTrx-Px1 is H2O2-sensitive. (A) Comparison of the sequences of the H2O2-sensitive mammalian peroxiredoxins to the Plasmodium
peroxiredoxins discussed herein. (B) & (C) Active sites of the reduced and oxidized forms of PvTrx-Px1 exemplifying the features described in the
text of the H2O2-sensitive peroxiredoxins.
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Page 7 of 18Figure 4 Plasmodium peroxiredoxin oligomeric structures. Oligomeric structures of (A) PvTrx-Px_ox and (B) PyTrx-Px1_ox showing the
internal dimer. (C) The close-up view of a hydrogen bond at the A-type interface between the side chain of Lys81 from one monomer (cyan)
and the main chain carbonyl of Lys172 from an adjacent molecule (grey) with the 2mFo-dFc electron map contoured at 1.0 s (blue mesh). (D)
Examples of the novel hydrogen bonding interactions of the PyTrx-Px_ox are circled in black. The panel is simplified to show only a tetramer for
clarity, but indeed there are hydrogen bonding interactions across all of the A-type interfaces. Although the hydrogen bonding interaction is at
the A-type interface, it is formed between distant chains in an A-C fashion (where A, B, C, and D chains are pink, grey, cyan, and green,
respectively). For example, in the pink chain Lys172 carbonyl backbone is shown hydrogen bonding with the side chain of Lys81 from the cyan
chain (A-C fashion) and in the grey chain Lys81 is hydrogen bonding with the main chain carbonyl of green Lys172 (B-D fashion). A comparison
of the A-type interactions (E) and B-type interactions (F) between PvTrx-Px1 and PyTrx-Px1 is shown. In (E) and (F) the monomer structures (dark
green and purple) are structurally aligned (rmsd = 0.573 Å), so that upon comparison of the corresponding dimeric partners the difference in
the interfaces are shown (PvTrx-Px1 shown in light greens and PyTrx-Px1 shown in light blue/purple). A full alignment of the A-type dimers gives
a rmsd = 1.065 Å, while a full alignment of the B-type dimers gives a rmsd = 3.137 Å.
Qiu et al. BMC Structural Biology 2012, 12:2
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Page 8 of 18Px1_ox and PvTrx-Px1_red arrange in a decameric fash-
ion (according to our crystal structure), which from a
survey of peroxiredoxin structures deposited to the PDB
is the most common oligomerization. According to our
results (namely a crystal structure and the gel filtration
elution times characteristic of the higher order oligomer
and not a dimer), the toroid PyTrx-Px1 structure is
unique in that it is octameric (Figure 4B). PvTrx-Px1_ox
and PvTrx-Px1_red decamers have internal diameters of
~58 Å, while PyTrx-Px1_ox octameric diameter is corre-
spondingly smaller at ~50 Å. Li et al. reportedly solved
the structure of another octameric peroxiredoxin (Myco-
bacterium tuberculosis AhpE), but this has been
disputed as simply a crystallographic artifact, as predo-
minately dimers were observedi ng e lf i l t r a t i o na n dt h e
octameric interface is not extensive and does not involve
the typical interfaces [32,33]. It could be argued that the
octameric arrangement of PyTrx-Px1 is a result of the
crystal packing of PyTrx-Px1_ox dimers; however, no
dimers were observed in the gel filtration of the PyTrx-
Px1_ox sample which was done at a high μM concentra-
tion comparable to crystallization experiments. Interest-
ingly, there is a hydrogen bonding interaction in the
PyTrx-Px1 structure between distant monomers and
more specifically between adjacent dimers, where the C-
terminal tail of one monomer crosses its dimeric partner
to hydrogen bond to next monomer. Contributing to the
stability of the octamer, the side chain of Lys81 is within
hydrogen bonding distance (3.2 Å) of the backbone car-
bonyl of Lys172 (Figure 4C). Indeed, there are interac-
tions between each of the pairs A-C, B-D, C-E, D-F, E-
G ,F - H ,G - A ,a n dH - B ,a so n ew o u l de x p e c tf r o ms y m -
metry (Figure 4D). Although these 2 residues are con-
served in PvTrx-Px1, there is no similar interaction in
the PvTrx-Px1_ox or PvTrx-Px1_red structures (where
the corresponding residues are Lys87 and Gly177).
There is 83% sequence identity between the P. yoelii
and P. vivax Trx-Px1 enzymes, so the differences in oli-
gomeric state were not predictable. Previous reports
have identified alterations of the B-type interface as con-
ferring the different orders of oligomeric state, while the
A-type interface remains constant [33]. An alignment of
the Ca’s of a monomer from the decameric PvTrx-
Px1_ox with a monomer from octameric PyTrx-Px1_ox
(rmsd = 0.573 Å) is shown in Figure 4E, F to illustrate
the overlap of each accompanying monomer in the A-
type interface and B-type interface, respectively. In Fig-
ure 4E, the corresponding A-type interface dimer is
shown for the octamer and decamer which visually
appears to preserve the overlap for their respective
dimeric partners. Indeed, a structural alignment of the
A-type dimers between the octamer and decamer gives
a rmsd of 1.065 Å. Figure 4F shows the same monomers
aligned, but in this case, their respective B-type interface
with the dimeric partner from the opposite side shown.
Here, one can see that the overlap is poor which is also
reflected as a much larger rmsd of 3.137 Å for the align-
ment of octameric and decameric B-type dimeric part-
ners. In order to more directly compare the interfaces,
each monomer is simplified to the 2 Ca’so fc o n s e r v e d
leucine residues at its core, for example, Leu 102 and
Leu139 from PvTrx-Px1and corresponding Leu96 and
Leu133 from PyTrx-Px1 (Figure 5A, B, respectively). An
analysis of the changes between the PyTrx-Px1 octamer
and the PvTrx-Px1 decamer was undertaken using these
conserved core residues as a representation of each
monomer. Indeed, the model is validated, as the dis-
tance between the selected leucine residues (termed
core length) is conserved throughout each of the struc-
tures and is similar between the two structures (Figure
5D). The orientation (termed angle between the dimers)
and distance between the dimers within the oligomer is
also conserved between the PyTrx-Px1 octamer and
PvTrx-Px1 decamer (Figure 5D). On the other hand, the
orientation (termed angle between monomers) and dis-
tance between the monomers of the dimer (termed core
distance) is dramatically different between the octamer
and decamer. The observation that the different oligo-
merization is attributable to the interface within the
dimer suggests that the oligomerization is not an artifact
of crystallization and that the dimer itself is unique at
least in terms of its B-type interface.
Analysis of the structures of PyTrx-Px1 and PvTrx-
Px1 identifies several key points of difference between
the structures that may account for difference in oligo-
merization. First of all, the presence of a hydrogen bond
between the dimers of PyTrx-Px1 (and not PvTrx-Prx1)
was already discussed (Figure 4C, D). Secondly, the C-
terminal tails have different orientations, such that they
are binding at different positions on the surface of their
respective dimeric partners (Figure 6). The tails are
bound by an intermolecular disulfide between CP and
CR, as well as a series of hydrophobic interactions. The
different binding orientations are linked to the orienta-
t i o no ft h es i d ec h a i no fac o n s e r v e da r g i n i n e( A r g 1 4 2
and Arg148 for PyTrx-Px1 and PvTrx-Px1, respectively)
(Figure 6A, B). In the case of PvTrx-Px1, the arginine is
buried and the C-terminal tail adopts the typical binding
pattern on the surface of its respective dimeric partner
(Figure 6D). As opposed to PyTrx-Px1 where the
equivalent arginine side chain is at the surface of the
protein obstructing the typical pathway, such that the
C-terminal tail adopts a different position at the surface
of its partner (Figure 6C). Using the NCBI Molecular
Modeling Database http://www.ncbi.nlm.nih.gov/Struc-
ture/MMDB/mmdb.shtml, a search was performed to
identify 3D structures to similar PyTrx-Px1. A manual
inspection of each the 2-Cys peroxiredoxins of the 143
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Page 9 of 18low redundancy hits (from the 1532 total hits) showed
no similarity in orientation to the PyTrx-Px1 C-terminal
tail, as expected as no other toroid octameric peroxire-
doxins are known to date. A second point of differentia-
tion between the two structures is a loop with the
conserved sequence
142NNLA(I/L)GRS
149 (numbering
from PvTrx-Px1 (PDB: 2H66)) that connects a5a n db7
(b-sheet involved in the peroxiredoxin B-type interface)
and contains the afore mentioned buried/surface Arg.
The loops from each structure adopt different confor-
mations that put Arg142 at the surface for PyTrx-Px1
and the corresponding Arg148 buried for PvTrx-Px1.
Although the PvTrx-Px1 structure is from a full-length
construct, only a structure with an N-terminal trunca-
tion of 6 residues crystallized sufficiently well for data
collection in the case PyTrx-Px1. Although both
Figure 5 Scheme describing the differences in oligomerization. (A) The Ca’s from 2 conserved leucine residues (i.e. Leu 102 and Leu139)
are shown for PvTrx-Px1. Two dimers are highlighted: the first comprised of blue and green monomers and second comprised of yellow and
orange monomers. (B) The Ca’s from 2 conserved leucine residues are shown (i.e. Leu96 and Leu133 in PyTrx-Px1). Two dimers are highlighted:
the first comprised of green and purple monomers and second comprised of yellow and blue monomers. (C) The same spheres are shown from
(A) from a different angle and scale with a grey line connecting the Lys’s of the same monomer for clarity. The distances and angles calculated
(by Pymol) in the next panel are defined. Note that these were made for the sole purpose of comparing the orientation of the monomers
within the structure at the B-type interface and at the A-type interface. (D) Summary table showing the average distances and angles calculated
for each of the measurements indicated in the previous panel. The standard deviations are not shown for clarity, but are less than 0.5% in each
case.
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Page 10 of 18Figure 6 Role of C-terminal tail and NNLA(I/L)GRS-loop in the determination the oligomerization of PyPrx-Tr1. (A) and (B) Two views of
the oxidized monomers of PyTrx-Px1 (blue) and PvTrx-Px1 (yellow) showing their structural differences: C-terminal tail adopts a different
orientation in each structure, NNLA(I/L)GRS-loop also adopts a different orientation in each structure (see panel B), and the Arg adopts a surface
position in PyTrx-Px1 and a buried position in PvTrx-Px1. Note that chain I from PDB: 2H66 is used because it is most complete at the C-
terminus. As well, portions of the structures in (B) are hidden to facilitate the view of the loop (including up to Tyr42 from the N-terminus and
from Ala56 to Asp 77). (C) In order to demonstrate how the C-terminal tail positions itself in the dimer, a hybrid surface-cartoon rendering of
PyTrx-Px1 shows the orientation of the C-terminal tail and the NNLA(I/L)GRS loop in grey. (D) and (E) For comparison, the hybrid surface-cartoon
renderings of PvTrx-Px1 show the orientation of the C-terminal tail and the NNLA(I/L)GRS loop in grey. Note that (D) is from chains I and J
which only shows a complete C-terminal chain for I. As well, for (E) chains C and D are used which both truncate around CR for the C-terminal
tail, but show that the C-terminus is the same up to this point.
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only be cleaved from the PvTrx-Px1 construct. Even
after several days at room temperature (where typical
conditions require an overnight reaction at 4°C), the
His6-tag remained intact on PyTrx-Px1. Although the
tag is partially visible in PyTrx_Px1 case(
-3AFQG
1 from
PDB: 2H01), it is not close enough to the conserved
loop in both cases to affect its orientation. Further stu-
dies will determine what roles the structural features
identified herein (i.e. the hydrogen bond between the
dimers, the N-terminal tail, the surface/buried arginine,
the NNLA(I/L)GRS-loop, and the C-terminal tail) play
in the stoichiometry of oligomerization of these Trx-Px1
enzymes.
Crystal structure of PyPrx6 with product bound
The PyPrx6-SO2H crystal structure has been solved at
2.3 Å (PDB ID: 3TB2). It is 47% identical to its closest
human orthologue and shares 76% sequence identity
with its P. falciparum orthologue. The closest available
structure by sequence (at 48% sequence identity) is Are-
nicola marina peroxiredoxin 6 which was further identi-
fied as a 2-Cys Prx [34], but it also shares 47% sequence
identity with a solved structure for a human 1-Cys Prx
[35]. Overall, the human (PDB ID: 1PRX) and P. yoelii
structures are very similar with a core thioredoxin-fold
and a C-terminal domain connected by both an
extended helix a5 and a loop. The core rmsd is 1.38A
for 401 aligned residues in both structures. The C-term-
inal domain of PyPrx6 that comprised of 3 b-strands
and a a-helix is larger than the C-terminal domain from
the Prx1 subfamily (Figure 1D). This domain from each
monomer extends over the other forming a domain
swapped dimer.
T h ea c t i v es i t eC P (Cys47) is located at the bottom of
a narrow pocket (~4 Å by ~7 Å) at the end of helix a2.
There are 2 additional densities in each of the 4 active
site pockets of the asymmetric unit (Figure 7) which are
best filled by a glycerol molecule (from the purification
buffer used which contained 5% glycerol) and fitting the
CP residues to their sulfinic acid derivatives (CP-SO2H).
Previously, the CP has been structurally characterized in
the whole range of oxidation states (including CP-SH,
CP-SOH, SP-SO2H, CP-SO3H, and CP-SS-CR) [36]; and
our data agrees with those sulfinic acid structures pre-
viously studied. As well, nearly 20 peroxiredoxin struc-
tures have either substrate or what has been termed
s u b s t r a t ea n a l o g u eb o u n di ntheir active site pockets,
including H2O2, benzoate, acetate, dithiothreitol (oxi-
dized), ethylene glycol, glycerol, sulfate, citrate, and for-
mate [36].
In order to understand the reaction mechanism, our
focus is on the comparison of structures with substrate
(H2O2) or glycerol bound. The binding of H2O2 to
Aeropyrum pernix Tpx (thiol peroxidase) has been
structural characterized (PDB: 3A2W and 3A2V) [38].
Further work on these structures and comparisons to
other ligand bound peroxiredoxin structures previously
showed that oxygen atoms of the ligands overlap with
the proximal (relative to CP)o x y g e na t o m( O A)a n d / o r
the distal oxygen atom (OB) of bound H2O2 [37]. Inter-
estingly, the glycerol molecule found in these structures
can adopt all three possibilities: (1) in one monomer of
ApT r x( P D B :3 A 2 W )i ti sf o u n dw i t has i n g l eo x y g e n
atom overlapping OA (Figure 7C, pink); (2) in another
monomer of ApTrx (PDB: 3A2W), it is found to overlap
with both OA and OB (Figure 7C, pink); and (3)
reported for the first time, in our structure of PyPrx6,
the glycerol is observed to overlay with only OB (Figure
7C, purple). Previously, only 2 anionic ligands (sulfate
and citrate) were observed to occupy OB alone (see
PDB: 1TP9 and 3DRN) [37]. Despite variations in the
backbone orientation of the glycerol in our structure
(which is also seen in the ApTrx glycerol bound chains
and presumably due to its conformational flexibility),
the binding of all 4 glycerol molecules shows that each
binds with the terminal hydroxyl in a similar position
overlapping with OB site (Figure 7B). Oxygen atoms at
position OA are postulated to be a mimetic for the sub-
strate bound in a Michaelis complex ready for attack by
the nucleophilic CP, while oxygen atoms at position OB
are indicative of the leaving group (H2Oo ra l c o h o l )
[37]. As such, it can be suggested that the glycerol posi-
tioned with its terminal hydroxyl at OB is in a product
bound configuration. Although there is variability in the
binding of the remainder of the glycerol molecule, the
alkyl group is always directed away from the active site
pocket and the oxygen of the leaving group is in close
proximity to a conserved threonine (Thr44). This
arrangement suggests that it may be the proton donor,
although others have suggested that this threonine func-
tions as a hydrogen bond acceptor as it deprotonates
the incoming substrate for attack by the CP thiolate and
that bulk solvent is responsible for the protonation of
t h el e a v i n gg r o u p[ 3 7 ] .T h e r e f o r e ,t h ea c t i v es i t ep o c k e t
is adapted to accommodate different substrates (and
thus products), which is exemplified through the struc-
tural flexibility exhibited in the product bound glycerol
shown herein. As well, the OB position appears to be
designated for the oxygen of the leaving group and is
well positioned for protonation by a conserved
threonine.
The conserved residues of the CP loop comprised of
40PxxxxTxxCP
47 and conserved Arg127 (numbering
refers to PyPrx6) are implicated in catalysis (Figure 8).
For the conserved arginine in both PyPrx6 (Arg127) and
ApTrx￿H2O2 structures, it adopts position I, typical of
Prx6, which bears a conserved arginine (Arg152) and
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and supports the positioning by a hydrogen bonding
network, as previously described [37]. The active site
geometry is fully folded (FF) and is virtually identical to
that of the ApTrx￿H2O2. As was recently described, the
nucleophilic CP (as activated by a main chain amide N-
H and the conserved arginine guanidinium) is expected
to act as a thiolate and attack the substrate in an SN2
fashion [37]. These hydrogen bonds, as well as those
secondary ones from the backbone carbonyls and the
glutamic acid/second conserved arginine, surrounding
the CP are preserved between the ApTrx x￿H2O2 and
the PyPrx6￿glycerol structures suggesting that the sulfi-
nic acid form may be activated, and thus sufficiently
nucleophilic (similar to its full reduced state) within the
a c t i v es i t et ou n d e r g oaf u r t h er reaction with substrate.
T h i sw o u l dr e s u l ti nas u b s e q u e n to x i d a t i o no ft h e
active site to the sulfonic acid. Indeed, this form of the
CP has been structural characterized in other cases
(PDB: 2CV4, 2NVL, and 1XIY). The conserved proline
serves as a barrier to solvent, while the main chain of
the CP loop provides hydrogen bonds to the CP and the
Figure 7 PyPrx6 active site depicting the sulfinic acid and the binding orientations of glycerol. (A) Fc-Fo omit map (1.62 s) of the active
site from the 4 chains within the asymmetric unit of PyPrx6 (PDB: 3TB2) showing the density assigned to both the sulfinic acid of CP and the
glycerol bound in the active site. Glycerol and sulfinic acid are labelled as GOL and CSD, respectively. Note that the carbons are yellow, sulfur is
green, oxygen is red, and nitrogen is blue. (B) A comparison of the binding orientations of each of the glycerol molecules of PyPrx6 relative to
H2O2 derived from an alignment with the ApTrx-H2O2 structure (PDB: 3A2V) with our PyPrx6 structure. The H2O2 is shown as the red oxygen
atoms with positions OA and OB labelled, while the 4 glycerol molecules in the PyPrx6 structure are shown with different coloured backbones
and red oxygen atoms. Note that in each case, the terminal oxygen of the glycerol molecule aligns with position OB. (C) For comparison, from a
similar structural alignment the known binding orientations for glycerol (from PDB: 3A2W (ApTrx, chains A and C with the glycerol molecules
depicted in pink and green, respectively) are compared to the same binding of H2O2 (PDB: 3A2V). Note that for ApTrx chain A, the glycerol
terminal oxygen aligns with position OA, while the glycerol molecule from ApTrx chain C has oxygen atoms aligning with positions OA and OB
as was previously reported [37] All structural alignments derived from the alignment of the following conserved residues PxxxxTxxCP, as was
done previously [37].
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owing to the relative activity of an oxidized thiol relative
to a thiolate, the preservation of the hydrogen bonding
network about the active site cysteine, indicates that
sequential H2O2 reductions are possible.
Discussion
Plasmodium lacks the two major antioxidant enzymes of
eukaryotic cells, namely glutathione peroxidase and cat-
alase [39]. As such, the parasite is likely to rely on the
peroxiredoxin family to control peroxide production (as
well as other reactive oxygen and nitrogen species) dur-
ing critical stages of its lifecycle, for example during ery-
throcyte invasion when heme metabolism and immune
response pathways ensue. During the trophozoite stage
(feeding period), Prx enzymes accounts for 0.5% of the
total expressed protein [40]. One recent study suggests
that PfnPrx, the P. falciparium nuclear peroxiredoxin
might be essential in the erthyrocyte stage, as neither P.
falciparum or P. berghei knock-out lines could be gener-
ated despite several attempts and success with generat-
ing tagged nPrx-GFP fusion cell lines [14]. Analysis of
the growth of a P. berghei Trx-Px1 knockout also sug-
gests that Trx-Px1 is not essential for growth, but P. fal-
ciparum and P. bergei show differences in their
lifecycles [41]. There is a possibility that Trx-Px1 is
essential during the asexual growth of P. falciparum
[31]. Expression of Pf1-Cys Prx is elevated during the
trophozoite and early schizont stages (when the para-
sites are maturing during the liver phase) suggesting
that this subfamily detoxifies ROS, like those released
during heme metabolism [40]. Despite the important
roles of peroxiredoxins, whether inhibitors targeting
Plasmodium peroxiredoxins will lead to parasite death
remains to be determined.
Structural characterization of the 2-Cys Prx enzymes
has shown that the C- t e r m i n a lt a i l( r e f e r r e dt oa st h e
CR) is essential for stabilizing the octameric/decameric
arrangement of peroxiredoxins. When Trx-Px1 (or
another 2-Cys Prx) is oxidized to the disulfide form, the
CR loop is unfolded; and structural support of the octa-
mer/decamer/dodecamer interfaces are weakened giving
rise to dimer formation (as seen in part when our oxi-
dized PfTrx-Px1 is run on a gel filtration column).
When the CR loop is folded as in the reduced form, the
higher order oligomer is favoured because of increased
stabilization for the B-type interface which supports oli-
gomerization. The dramatic rearrangement of the C-
terminal tail and ensuing changes in stability are clearly
demonstrated in our structures from PyTrx-Px1 and
PvTrx-Px1 (both oxidized and reduced forms). However,
the high concentrations of protein used in crystallizing
the enzyme (and also apparently during most of our gel
filtration experiments) may account for the trapping of
the disulfide forms of these peroxiredoxins in their pre-
dicted unfavoured octameric/decameric/dodecameric
forms. Factors associated with the oligomeric forms pri-
marily include reduction of the active site disulfide, but
also, high or low ionic strength, low pH, high magne-
sium or calcium concentrations, and overoxidation of
the peroxidatic cysteine (Cys-SO2H) [28]. At physiologi-
cally relevant concentrations, peroxiredoxins can be
expected to exist as dimers awaiting reduction; and
upon reduction, the catalytic cycle is complete and the
reduced peroxiredoxin oligomerizes [23]. With data
from the novel octameric configuration of PyTrx-Prx1
studied herein, other specific structural features affecting
oligomerization are considered. The molecular basis for
octamer formation relies on the hydrogen bond between
the dimers which is facilitated by the positioning of the
C-terminal tail which in turn rests on interplay between
the surface/buried arginine of the NNLA(I/L)GRS-loop
and possibly the N-terminal tail. In vivo work directed
at the further characterization of the different sizes and
configurations of the oligomers will be necessary to fully
understand the biological implications.
Aside from being antioxidant proteins, 2-Cys Prx
(Prx1) has also been implicated in H2O2-mediated signal
transduction. Eukaryotic 2-Cys Prx enzymes are sensi-
tive to oxidative inactivation, while their bacterial ortho-
logues are robust with respect to overoxidation [30].
The Plasmodium 2-Cys Prx enzymes accordingly have
the 3 sequence motifs indicative of the H2O2-sensitive
peroxiredoxins, and as shown herein are structurally
identical with respect to sensitivity to H2O2 to known
Figure 8 Comparison of the active sites of PyPrx6￿glycerol with
ApTrx￿H2O2. A view into the active site from above shows select
main chain and side chain residues of PyPrx6 (PDB: 3TB2) in dark
grey (with the associated glycerol shown in purple/red). In light
grey the corresponding ApTrx (PDB: 3A2W) side chain residues are
shown (with the associated H2O2 shown in pink/dark red to
differentiate OA and OB). The structural alignment is derived from
the alignment of the following conserved residues PxxxxTxxCP,a s
was done previously [37].
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resting levels of H2O2, while permitting higher levels
during signal transduction.
The PyPrx6 structure presented herein has greatly
enhanced our understanding of the chemistry of the
peroxiredoxins. With a product bound configuration,
the residues supporting the leaving group are further
understood. There is flexibility for the alkyl chain, but
the OB position is indeed designated for the oxygen of
the leaving group. As well, the retention of hydrogen
b o n d sa b o u tt h ea c t i v es i t et h i o l( e v e ni na no x i d i z e d
state) indicates that it is poised for further reaction,
albeit at a reduced efficiency owing to the reduced activ-
ity of an oxidized thiol relative to a thiolate.
Conclusions
Our structural data and mass spectroscopy confirms
that PvTrx-Px1 is H2O2-sensitive peroxiredoxin. The
characterization of the oligomerization of PyTrx-Px1 has
identified structural features supporting its novel octa-
meric oligomerization. Previously unreported abnormal-
ities of the disulfide bond measurements in some of the
Prx crystal structures are brought to the forefront.
Finally, a crystal structure with an alcohol bound and
the CP oxidized gives a view to the product bound com-
plex providing insight into leaving group and the sus-
ceptibility of some peroxiredoxins to overoxidation.
These results enhance our understanding of the struc-
tural variations of the peroxiredoxin oligomers and the
nature of the catalysis by these remarkable enzymes.
Further work will lend insight into the biological impli-
cations of the oligomerization and how to exploit the
active site features in drug discovery programs.
Methods
Cloning, expression, and purification
Full-length P. falciparum Trx-Px1 encoded by PlasmoDB
ID: PF14_0368 http://plasmodb.org/plasmo/[42] was
cloned from P. falciparum 3D7 genomic DNA with a
His6-tag with an integrated thrombin cleavage site
(MGSSHHHHHHSSGLVPR*GS). Full-length P. knowlesi
Trx-Px1 encoded by PlasmoDB ID: PKH_126740
was cloned from P. knowlesi Hg e n o m i cD N Aw i t ha
His6-tag with an integrated TEV cleavage site
(MGSSHHHHHHSSGRENLYFQ*G). Full-length P. vivax
protein encoded by PlasmoDB ID:PVX_118545 with an
N-terminal His6-tag and TEV cleavage site (as above) was
cloned from a P. vivax Salvador I cDNA library (gener-
ously provided by Prof. Liwang Cui of Penn State Univer-
sity). Full-length P. yoelii protein encoded by PlasmoDB
ID: PY00414 (Trx-Px1) was cloned from P. yoelii 17XNL
genomic DNA with an N-terminal His6-tag and inte-
grated TEV protease site (as above). Full-length P. yoelii
protein encoded by PlasmoDB ID: PY04285 (Prx6) was
cloned from P. yoelii 17XNL genomic DNA with an N-
terminal His6tag with different integrated TEV protease
site (MGSSHHHHHHSSGRENLYFQ*GHM) and C-
terminal addition (GS). All enzymes were expressed and
purified according to methods described previously [26]
except for PyPrx6 which was expressed from Studier
auto-induction media [27].
Characterization
All mass spectra were completed on an Agilent LC-MS-
TOF (Model #G1969A) running in positive ion mode
and integrated with an Agilent 1100 series HPLC using
an Agilent Poroshell 300-SB-C3 column for fast bind-
ing/elution desalting. All gel filtration experiments were
complete on a AKTA purifier chromatography system
(GE Healthcare Life Sciences) equipped with a Superdex
S200 gel filtration column that was calibrated with 4
samples (bovine thyroglobulin (670 kDa), bovine g-glo-
bulin (158 kDa), chicken ovalbumin (44 kDa), and horse
myoglobin (17 kDa) all from Bio-Rad) in 10 mM
HEPES, pH 7.4 and 500 mM NaCl.
Crystallization and structure determination
PvTrx-Px1_ox with the His6-tag intact was crystallized
by mixing 1.5 μL of protein (at a concentration of 8
mg/mL in a buffer of 10 mM HEPES, pH 7.5, 500 mM
NaCl) with 1.5 μL of reservoir solution containing 5%
Peg 4 K, 50 mM NaAc, 100 mM NaAc, pH 4.6 in a
hanging drop vapour diffusion setup with over 350 μL
of reservoir solution at 18°C in VDXm plates (Hampton
Research). Crystals appeared overnight and were
flashed-cooled in liquid nitrogen (N2(l)) for data collec-
tion. Single wavelength data was collected at a synchro-
tron source (APS Beamline 17-ID) with a CCD detector
(ADSC quantum 210). PvTrx-Px1_red with the His6-tag
intact was crystallized using the hanging drop vapour
diffusion method in a VDXm plate with 350 μLo f
mother liquor at 18°C. 1.5 μL of the protein solution
treated with 5 mM TCEP was mixed with 1.5 μLo ft h e
reservoir solution containing 19% PEG 3350, 150 mM
lithium citrate. Crystals appeared overnight. Data for
crystals flash frozen in N2(l) was collected at the syn-
chrotron (APS Beamline 17-BM) with a CCD detector
(MAR CCD 165 mm). PyTrx-Px1 with the His6-tag
intact was crystallized at 4.3 mg/mL using the sitting
drop vapour diffusion method in a Linbro plate with
300 μL of mother liquor at 18°C. 1.5 μLo ft h ep r o t e i n
solution was mixed with 1.5 μL of the reservoir solution
containing 1.6 M ammonium sulfate, 100 mM HEPES,
pH 6.8, 200 mM NaAc, 20 mM NaBr, 5% ethylene gly-
col. Crystals appeared in 3-5 days and were flash frozen
in N2(l) with data collected on a Rigaku FRE Superbright
rotating anode with an RAXIS IV plate reader. PyPrx6
with the His6-tag intact at 15 mg/mL was crystallized by
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plate. The plate was set with 1.5 μL protein plus1.5 μL
buffer in each drop and 350 μL reservoir volume per
well. Crystals emerged in 23% Peg 3350, 0.1 M Bis-Tris
pH 5.5, 200 mM (NH4)2SO4 and 5% ethylene glycol at
20°C. MAD data from a crystal flash frozen in N2(l) was
collected at the synchrotron (APS Beamline 17-ID) with
a CCD detector (ADSC Quantum 4).
Data were processed using the HKL2000 package [43].
Each structure was solved by molecular replacement
using modified homology models created with the
FFAS03 program [44]. The structures were refined by
iterative rounds of manual building in Coot [45] and
refinement using refmac5 from CCP4 package [46]. All
structures were refined with good statistics and geome-
try, checked with MOLPROBITY [47]. Final statistics
and data information for each structure can be found in
Table 3. Figures for structural models were created
using the Pymol visualization software http://www.
pymol.org.
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Mean Bfactor 45.74 38.6 37.8 40.0
Ramachandran Favored (%) 95.37 95.21 91.86 98.01
Ramachandran Disallowed (%) 0.48 0.33 0.58 0.00
RMS deviations
Bond length (Å) 0.0161 0.0083 0.0090 0.0086
Bond angle (°) 1.6765 1.2250 1.2343 1.1004
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